-
are to understand fundamental biological mechanisms, develop biomarkers and novel therapeutic strategies to mitigate progressive kidney failure in native and allograft kidneys. Our well-funded research opportunities
-
failure, structural heart disease, and precision medicine. The Oikonomou Group is based within the Section of Cardiovascular Medicine and is affiliated with the Yale Cardiovascular Data Science (CarDS
Searches related to failure
Enter an email to receive alerts for failure positions